UBS AM’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-34,387
| Closed | -$2.47M | – | 2868 |
|
|
2024
Q1 | $2.47M | Sell |
34,387
-96
| -0.3% | -$6.9K | ﹤0.01% | 1578 |
|
|
2023
Q4 | $6.86M | Sell |
34,483
-111
| -0.3% | -$22.1K | ﹤0.01% | 1126 |
|
|
2023
Q3 | $4.6M | Buy |
+34,594
| New | +$4.6M | ﹤0.01% | 1240 |
|
|
2022
Q4 | – | Sell |
-1,498
| Closed | -$288K | – | 2712 |
|
|
2022
Q3 | $288K | Hold |
1,498
| – | – | ﹤0.01% | 2502 |
|
|
2022
Q2 | $219K | Buy |
+1,498
| New | +$219K | ﹤0.01% | 2563 |
|
|
2022
Q1 | – | Sell |
-1,831
| Closed | -$538K | – | 2813 |
|
|
2021
Q4 | $538K | Hold |
1,831
| – | – | ﹤0.01% | 2523 |
|
|
2021
Q3 | $455K | Buy |
1,831
+943
| +106% | +$234K | ﹤0.01% | 2534 |
|
|
2021
Q2 | $226K | Buy |
+888
| New | +$226K | ﹤0.01% | 2696 |
|